EGFR/DNA gyrase B Ligand 1
EGFR/DNA gyrase B Ligand 1 is an antibacterial agent that targets EGFR and DNA gyrase B. EGFR/DNA gyrase B Ligand 1 binds to DNA gyrase B and EGFR. EGFR/DNA gyrase B Ligand 1 exhibits cytotoxicity against cancer cells. EGFR/DNA gyrase B Ligand 1 is used in research related to non-small cell lung cancer, Escherichia coli, and Klebsiella pneumoniae.
For research use only. We do not sell to patients.
- Formula: C24H19ClN4O4S
- Molecular Weight:494.95
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
14.59 μg/mL
|
Cytotoxicity against human lung adenocarcinoma A549 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay.
Cytotoxicity against human lung adenocarcinoma A549 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay.
|
42558029 |
In Vitro
EGFR/DNA gyrase B Ligand 1 (Compound 8c) (24 h) exhibits potent cytotoxicity against A549 human lung cancer cells with an IC50 value of 14.59 µg/mL[1].
EGFR/DNA gyrase B Ligand 1 (1-1000 µg/mL; 16-18 h) exhibits activity against Gram-negative bacteria (E. coli and K. pneumoniae), but shows limited potency against the Gram-positive bacterium S. aureus[1].
EGFR/DNA gyrase B Ligand 1 fully complies with Lipinski's rule and is predicted to have good oral absorption[1].
EGFR/DNA gyrase B Ligand 1 binds to both EGFR and DNA Gyrase B, exhibiting superior affinity for DNA Gyrase B[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
Molecular Weight 494.95
-
Formula C24H19ClN4O4S
-
SMILES
O=C(NC1=CC=CC=C1)COC2=CC=CC=C2C3=NN=C(SCC(NC4=CC=C(Cl)C=C4)=O)O3
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)